Tag: NEH WEU EUR UNK USA NAM

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...

TerThera reached GMP status for their Terbium-161 product, improving clinical access by meeting the highest quality standards.

GMP TERBIUM-161 PRODUCT LAUNCHED BY TERTHERA BREDA, Netherlands, June 5, 2025 /PRNewswire/ -- TerThera B.V. has officially launched the world's first GMP-compliant Terbium-161 NCA, setting...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsNEH WEU EUR UNK USA NAM

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

El evento promocional «Oportunidad en China: Jinan, la ciudad de los manantiales» tuvo lugar en Madrid

Anime “KAGURABACHI” Unveils Chihiro Rokuhira Character Visual & Character Trailer

Tag: NEH WEU EUR UNK USA NAM

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

TerThera reached GMP status for their Terbium-161 product, improving clinical access by meeting the highest quality standards.

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us